Nucleic Acid Amplification, Detection and Diagnostics Market is expected to reach US$ 38,162.68 million by 2027

Deoxyribonucleic Acid (DNA) Segment by Nucleic Acid to Grow at Faster Pace during Forecast Period

According to The Insight Partners market research study of “Nucleic Acid Amplification, Detection, and Diagnostics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Nucleic Acid, Process, Product Type, Technology, Application, End User, and Geography”, the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019. The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027. The report highlights trends prevailing in the global nucleic acid amplification, detection, and diagnostics market and the factors driving market along with those that act as hindrances.

Based on nucleic acid, the global nucleic acid amplification, detection, and diagnostics market is segmented into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). In 2019, the deoxyribonucleic acid (DNA) segment held the largest share of the market; also, the same segment is estimated to register the highest CAGR in the market during the forecast period. Factors such as rising adoption of DNA detection and amplification for disease diagnosis are estimated to contribute to the deoxyribonucleic acid (DNA) segment growth.

The growth of the nucleic acid amplification, detection, and diagnostics market is attributed to the factors such as increasing prevalence of chronic conditions and increasing demand for accurate and modern diagnostic measures. However, lack of expertise and inadequate infrastructure in emerging countries is likely to restraint the growth of the market during the forecast period.

The emergence of coronavirus is expected to have positive impact on the market growth. As nucleic acid related diagnostic technologies offer superior outcomes, majority of the market players are focusing on the product development equipped with nucleic acid tests. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which deterred the market growth by certain extent.  

BD, bioMerieux SA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Danaher, QIAGEN, Abbott, Meridian Bioscience, Inc., and F. Hoffmann-La Roche Ltd. are among the leading companies operating in the nucleic acid amplification, detection, and diagnostics market.  

Global Nucleic Acid Amplification, Detection, and Diagnostics Market, By Regions, 2019 (%)

---

Nucleic Acid Amplification, Detection and Diagnostics Market to Grow at a CAGR of 13.4% to reach US$ 38,162.68 million from 2020 to 2027

Download Free Sample

---

Nucleic Acid Amplification Detection and Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Nucleic Acid (Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)); Process (Amplification, Detection, Diagnostics); Product Type (Assays, Kits and Reagents, Systems); Technology (Polymerase Chain Reaction (PCR), Isothermal Amplification Technology, Direct Nucleic Acid Detection, Next Generation Sequencing (NGS), CRISPR-Cas9); Application (Infectious Diseases, Genetic Diseases, Forensic Testing, Paternity Testing, Oncology, Others); End User (Hospital and Clinics, Diagnostic Centers, Research Institutes, Others), and Geography

The report segments Global Nucleic Acid Amplification, Detection, and Diagnostics Market as follows:

By Nucleic Acid

• Deoxyribonucleic Acid (DNA)
• Ribonucleic Acid (RNA)

By Process

• Diagnostics
• Amplification
  • Transcription-Mediated Amplification (TMA)
  • Loop-Mediated Isothermal Amplification (LMIA)
  • Strand Displacement Amplification (SDA)
  • Helicase-Dependent Amplification (HDA)
  • Nucleic Acid Sequence-Based Amplification (NASBA)
  • Others
• Detection

By Product Type

• Kits and Reagents
• Assays
• Systems

By Technology

• Polymerase Chain Reaction (PCR)
  • Quantitative PCR (qPCR)
  • Reverse-Transcriptase (RT–PCR)
  • Multiplex PCR
  • Nested PCR
  • In-situ PCR
  • Others
• Next Generation Sequencing (NGS)
• Isothermal Amplification Technology
  • Target Amplification Systems
  • Probe Amplification Systems
  • Signal Amplification Systems
  • Direct Nucleic Acid Detection
  • Aptamers
  • DNA Biosensors
  • Others
• CRISPR-Cas9

By Application

• Infectious Diseases
• Genetic Diseases
• Oncology
• Forensic Testing
• Paternity Testing
• Others

By End User

• Hospital and Clinics
• Diagnostic Centers
• Research Institutes
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
• South & Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South & Central America